Загрузка...
Corticosteroids alleviate adverse events associated with enzalutamide in patients with metastatic castration-resistant prostate cancer
The aim of the present study was to investigate the impact of the combined use of corticosteroid on adverse events (AEs) induced by enzalutamide (Enz) in patients with metastatic castration-resistant prostate cancer (mCRPC). The cohort of the present study included 121 consecutive patients with mCRP...
Сохранить в:
| Опубликовано в: : | Mol Clin Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087477/ https://ncbi.nlm.nih.gov/pubmed/32257208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2020.2013 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|